Trials / Conditions / Hypercholesterolaemia

Hypercholesterolaemia

36 registered clinical trials studyying Hypercholesterolaemia — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia NCT06974266	Moon (Guangzhou) Biotechnology Co., Ltd.	N/A
Completed	Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coa NCT07170852	Humanis Saglık Anonim Sirketi	Phase 1
Recruiting	LATAM LOWERS LDL-C NCT06501443	Novartis Pharmaceuticals	Phase 4
Active Not Recruiting	Impact of Phytosterol-Rich Extract on Lipid Profile NCT06657456	Desirée Victoria Montesinos	N/A
Completed	Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid NCT06923956	Humanis Saglık Anonim Sirketi	Phase 1
Recruiting	Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy NCT07375225	Federico II University	—
Recruiting	A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias NCT07491172	CRISPR Therapeutics AG	Phase 1
Active Not Recruiting	Specified Drug-use Survey of Leqvio for s.c. Injection. NCT06275724	Novartis Pharmaceuticals	—
Active Not Recruiting	Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outc NCT06008756	Merck Sharp & Dohme LLC	Phase 3
Completed	Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Renal Impairment Study (MK-0616-020) NCT05934292	Merck Sharp & Dohme LLC	Phase 1
Completed	A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels NCT04058834	Novo Nordisk A/S	Phase 1
Completed	An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholest NCT03510884	Sanofi	Phase 3
Completed	A Study of PCSK9 Inhibitor AK102 in Healthy Subjects NCT04169386	Akeso	Phase 1
Completed	Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients W NCT03415178	Sanofi	Phase 3
Terminated	Study to Evaluate the Safety of Repatha® in Pregnancy NCT02906124	Amgen	—
Completed	An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents Wit NCT02890992	Sanofi	Phase 2
Completed	Efficacy of Lactobacillus Mucosae DPC6426 on Blood-lipids NCT07519967	University College Cork	N/A
Completed	Chart Review of Repatha® in Subjects With Hyperlipidaemia NCT02770131	Amgen	—
Completed	Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patie NCT02585778	Sanofi	Phase 3
Completed	The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabol NCT02065180	Universiteit Antwerpen	Phase 4
Completed	Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Lev NCT01935674	Juan A. Arnaiz	Phase 4
Completed	Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin. NCT01779687	Radboud University Medical Center	Phase 1
Completed	Rosuvastatin Calcium Bioequivalence Study - Fast NCT01711749	GlaxoSmithKline	Phase 1
Completed	Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Pati NCT01617655	Sanofi	Phase 3
Completed	Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values NCT01483950	AstraZeneca	—
Completed	Acotral® Versus Zetia® Ezetimibe Bioequivalance Study. NCT01597700	GlaxoSmithKline	Phase 1
Completed	Dose Effect of Limicol on (LDL)-Cholesterol Levels NCT01354340	Lescuyer Laboratory	N/A
Completed	Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-Co NCT01257971	AstraZeneca	—
Completed	Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia NCT01352897	AstraZeneca	—
Completed	Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients NCT00695539	AstraZeneca	—
Terminated	Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg NCT00427960	AstraZeneca	Phase 4
Completed	TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060) NCT00328523	Organon and Co	Phase 3
Completed	PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin NCT00329173	AstraZeneca	Phase 3
Completed	Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435) NCT00653835	Organon and Co	Phase 4
Completed	Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women NCT00163163	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Completed	OLE Study to Evaluate Safety / Efficacy of ZD4522 NCT00654303	AstraZeneca	Phase 3